Williams Syndrome (WS) is a genetic syndrome with features that may include vascular stenoses, neuro-developmental changes, and a variety of endocrine and metabolic abnormalities, including impaired glucose metabolism and abnormal body composition. Approximately 75% of adults with WS have impaired glucose tolerance or diabetes on oral glucose tolerance testing (OGTT). In addition, clinical observations and preliminary data suggest increased overall body fat in these individuals, as well as a relative increase in fat deposition in the lower extremities. However, glucose and lipid metabolism in WS remain incompletely characterized. The purpose of the current study is to carefully describe glucose metabolism and lipid parameters in people with WS.
Study Type
OBSERVATIONAL
Enrollment
24
Massachusetts General Hospital
Boston, Massachusetts, United States
2-hour glucose
Blood glucose concentration two hours after drinking a sugary drink (oral glucose tolerance test)
Time frame: Baseline
Percent body fat
percent body fat as measured by whole body dual-energy xray absorptiometry (DXA) scanning
Time frame: Baseline
Low-density lipoprotein cholesterol (LDL)
Time frame: Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.